JENNIFER FISHER: Open Payments
NPI 1902363492 · MILFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,199 in 52 payments from 17 companies in 2025. Trend: 2023 $999 · 2024 $1,096 · 2025 $2,199
Food & beverage: $2,099Education: $100
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $357 |
| LEO Pharma Inc. | 5 | $351 |
| UCB, Inc. | 4 | $306 |
| ABBVIE INC. | 12 | $278 |
| Regeneron Healthcare Solutions, Inc. | 3 | $276 |
| Janssen Biotech, Inc. | 5 | $152 |
| Lilly USA, LLC | 5 | $122 |
| E.R. Squibb & Sons, L.L.C. | 3 | $89 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
| Janssen Scientific Affairs, LLC | 1 | $46 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, ANZUPGO, TREMFYA, EBGLYSS, Sotyktu, ADBRY.
Industry payments across CT — which companies pay providers there.
